AcquirerTargetPrice
Astellas PharmaOcata Therapeutics$379 million
Apollo Global ManagementRegionalCare Hospital PartnersN/A
Virginia Mason Health SystemMemorial Family of ServicesMerger
Janssen BiotechRights to oxyntomodulin-based therapies$105 million